359 related articles for article (PubMed ID: 37497234)
21. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin inhibition of CFA-induced lymphangiogenesis in PLN is independent of mast cells.
Ji RC; Eshita Y
Mol Biol Rep; 2014; 41(4):2217-28. PubMed ID: 24420861
[TBL] [Abstract][Full Text] [Related]
23. Single-cell analysis unveils activation of mast cells in colorectal cancer microenvironment.
Xie Z; Niu L; Zheng G; Du K; Dai S; Li R; Dan H; Duan L; Wu H; Ren G; Dou X; Feng F; Zhang J; Zheng J
Cell Biosci; 2023 Nov; 13(1):217. PubMed ID: 38031173
[TBL] [Abstract][Full Text] [Related]
24. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer.
Song J; Chen W; Cui X; Huang Z; Wen D; Yang Y; Yu W; Cui L; Liu CY
Theranostics; 2020; 10(5):2327-2341. PubMed ID: 32089745
[TBL] [Abstract][Full Text] [Related]
25. Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancer.
Mao Y; Feng Q; Zheng P; Yang L; Zhu D; Chang W; Ji M; He G; Xu J
Int J Cancer; 2018 Nov; 143(9):2271-2280. PubMed ID: 29873076
[TBL] [Abstract][Full Text] [Related]
26. High tumor mast cell density is associated with longer survival of colon cancer patients.
Mehdawi L; Osman J; Topi G; Sjölander A
Acta Oncol; 2016 Dec; 55(12):1434-1442. PubMed ID: 27355473
[TBL] [Abstract][Full Text] [Related]
27. Lymphangiogenesis in colorectal cancer--prognostic and therapeutic aspects.
Sundlisaeter E; Dicko A; Sakariassen PØ; Sondenaa K; Enger PØ; Bjerkvig R
Int J Cancer; 2007 Oct; 121(7):1401-9. PubMed ID: 17640040
[TBL] [Abstract][Full Text] [Related]
28. Impact of KITENIN on tumor angiogenesis and lymphangiogenesis in colorectal cancer.
Oh HH; Park KJ; Kim N; Park SY; Park YL; Oak CY; Myung DS; Cho SB; Lee WS; Kim KK; Joo YE
Oncol Rep; 2016 Jan; 35(1):253-60. PubMed ID: 26496979
[TBL] [Abstract][Full Text] [Related]
29. Mast cells inhibit colorectal cancer development by inducing ER stress through secreting Cystatin C.
Song F; Zhang Y; Chen Q; Bi D; Yang M; Lu L; Li M; Zhu H; Liu Y; Wei Q; Qin H; Li J
Oncogene; 2023 Jan; 42(3):209-223. PubMed ID: 36402931
[TBL] [Abstract][Full Text] [Related]
30. Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer.
Nguyen J; Luk K; Vang D; Soto W; Vincent L; Robiner S; Saavedra R; Li Y; Gupta P; Gupta K
Br J Anaesth; 2014 Jul; 113 Suppl 1(Suppl 1):i4-13. PubMed ID: 24861561
[TBL] [Abstract][Full Text] [Related]
31. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
[TBL] [Abstract][Full Text] [Related]
32. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.
Lala PK; Nandi P; Majumder M
Cancer Metastasis Rev; 2018 Sep; 37(2-3):369-384. PubMed ID: 29858743
[TBL] [Abstract][Full Text] [Related]
33. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas.
Acikalin MF; Oner U; Topçu I; Yaşar B; Kiper H; Colak E
Dig Liver Dis; 2005 Mar; 37(3):162-9. PubMed ID: 15888280
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
35. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
[TBL] [Abstract][Full Text] [Related]
36. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
37. Mast cell marker gene signature in head and neck squamous cell carcinoma.
Cai Z; Tang B; Chen L; Lei W
BMC Cancer; 2022 May; 22(1):577. PubMed ID: 35610596
[TBL] [Abstract][Full Text] [Related]
38. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
[TBL] [Abstract][Full Text] [Related]
39. Innate effector cells in angiogenesis and lymphangiogenesis.
Varricchi G; Loffredo S; Galdiero MR; Marone G; Cristinziano L; Granata F; Marone G
Curr Opin Immunol; 2018 Aug; 53():152-160. PubMed ID: 29778674
[TBL] [Abstract][Full Text] [Related]
40. Relationship of mast cell density with lymphangiogenesis and prognostic parameters in breast carcinoma.
Keser SH; Kandemir NO; Ece D; Gecmen GG; Gul AE; Barisik NO; Sensu S; Buyukuysal C; Barut F
Kaohsiung J Med Sci; 2017 Apr; 33(4):171-180. PubMed ID: 28359404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
